Evidence map›Paper›PMID 38332397›Full record

ArticleInsights into imaging2024

Diagnostic accuracy of MRI, CT, and [

Ester P Olthof, Brenda J Bergink-Voorthuis, Hans H B Wenzel, Jordy Mongula, Jacobus van der Velden, Anje M Spijkerboer, Judit A Adam, Ruud L M Bekkers, Jogchum J Beltman, Brigitte F M Slangen and 8 more

Open access · goldAbstract read
In one paragraph

Article in Insights into imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neuroendocrine carcinoma of the cervix (NECC): A retrospective study of 175 Chinese patients.European journal of obstetrics & gynecology and reproductive biology: X · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Comparison of [Frontiers in oncology · 2025
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

Ester P OlthofDepartment of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, DT, Utrecht, 3511, The Netherlands. e.olthof@iknl.nl.ORCID http://orcid.org/0000-0003-1941-7693
Brenda J Bergink-VoorthuisDepartment of Health Technology and Services Research, Technical Medical Center, University of Twente, Enschede, The Netherlands.
Hans H B WenzelDepartment of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, DT, Utrecht, 3511, The Netherlands.
Jordy MongulaDepartment of Obstetrics and Gynaecology, Zuyderland Medical Center, Heerlen, The Netherlands.
Jacobus van der VeldenDepartment of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands.
Anje M SpijkerboerDepartment of Radiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Judit A AdamDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Ruud L M BekkersDepartment of Obstetrics and Gynaecology, Catharina Hospital, Eindhoven, The Netherlands.
Jogchum J BeltmanDepartment of Gynaecology, Leiden University Medical Center, Leiden, The Netherlands.
Brigitte F M SlangenDepartment of Obstetrics and Gynecology, Medical Center and GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Hans W NijmanDepartment of Obstetrics and Gynaecology, University Medical Center Groningen, Groningen, The Netherlands.
Ramon G V SmoldersDepartment of Gynaecological Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, The Netherlands.
Nienke E van TrommelCenter for Gynaecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Petra L M ZusterzeelDepartment of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.
Ronald P ZweemerDepartment of Gynaecological Oncology, University Medical Centre Utrecht, Utrecht Cancer Centre, Utrecht, The Netherlands.
Lukas J A StalpersDepartment of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Constantijne H MomDepartment of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands.
Maaike A van der AaDepartment of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, DT, Utrecht, 3511, The Netherlands.
Netherlands Comprehensive Cancer Organisation · NLAmsterdam University Medical Centers · NLRadboud University Nijmegen · NLErasmus MC Cancer Institute · NLLeiden University Medical Center · NLMaastricht University · NLThe Netherlands Cancer Institute · NLUniversity Medical Center Groningen · NLUniversity Medical Center Utrecht · NLUniversity of Amsterdam · NLUniversity of Twente · NLZuyderland Medisch Centrum · NL

Funding

KWF Kankerbestrijding [IKNL2019-12398]
6 · The paper itself

Abstract

objectivesImaging is increasingly used to assess lymph node involvement in clinically early-stage cervical cancer. This retrospective study aimed to evaluate the diagnostic accuracy of MRI, CT, and [

methodsWomen with International Federation of Gynaecology and Obstetrics (FIGO) 2009 stage IA2-IIA cervical cancer and pretreatment imaging between 2009 and 2017 were selected from the Netherlands Cancer Registry. Patient-based and region-based (i.e. pelvic and common iliac) nodal status was extracted from radiology reports. Pathology results were considered the reference standard for calculating accuracy indices. Multiple imputation was used for missing pathology to limit verification bias risk.

resultsNodal assessment was performed in 1676 patients with MRI, 926 with CT, and 379 with [

conclusions[ CRITICAL RELEVANCE STATEMENT: Accurate assessment of the nodal status in clinically early-stage cervical cancer is essential for tumour staging, treatment decision making and prognosis. KEY POINTS: • The accuracy of MRI, CT or [

Indexed as

Diagnostic imagingLymphatic metastasisSensitivity and specificityUterine cervical neoplasms

Identifiers

PMID38332397
PMCPMC10853153
OpenAlexW4391656572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.